MG r1‐Ag/37 LRP induces cell adhesion‐mediated drug resistance through FAK / PI 3K and MAPK pathway in gastric cancer-Reference-Cited by-同舟云学术

MG r1‐Ag/37 LRP induces cell adhesion‐mediated drug resistance through FAK / PI 3K and MAPK pathway in gastric cancer

Published:2014-05-12 Issue:6 Volume:105 Page:651-659
ISSN:1347-9032
Container-title:Cancer Science
language:en
Short-container-title:Cancer Sci

Author:

Sun Li¹,Liu Lili²,Liu Xiangqiang¹,Wang Yafang²,Li Mengbin¹,Yao Liping¹,Yang Jianjun¹,Ji Genlin³,Guo Changcun¹,Pan Yanglin¹,Liang Shuhui¹,Wang Biaoluo¹,Ding Jie¹,Zhang Hongwei¹,Shi Yongquan¹

Affiliation:

1. State Key Laboratory of Cancer Biology Xijing Hospital of Digestive Diseases Fourth Military Medical University Xi'anChina

2. Department of Oncology Tangdu Hospital Fourth Military Medical University Xi'anChina

3. Department of Anesthesiology Xijing Hospital Fourth Military Medical University Xi'an China

Publisher

Wiley

Subject

Cancer Research,Oncology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/cas.12414

Reference33 articles.

1. Adhesion to fibronectin via β1 integrins regulates p27kip1 levels and contributes to cell adhesion mediated drug resistance (CAM-DR)

2. Combination therapy of an anticancer drug with the FNIII14 peptide of fibronectin effectively overcomes cell adhesion-mediated drug resistance of acute myelogenous leukemia

3. Bortezomib overcomes cell adhesion-mediated drug resistance through downregulation of VLA-4 expression in multiple myeloma

4. Cell adhesion-mediated drug resistance (CAM-DR) protects the K562 chronic myelogenous leukemia cell line from apoptosis induced by BCR/ABL inhibition, cytotoxic drugs, and γ-irradiation

5. Wnt3/RhoA/ROCK signaling pathway is involved in adhesion-mediated drug resistance of multiple myeloma in an autocrine mechanism

Cited by 38 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Reconsideration of the laminin receptor 67LR in colorectal cancer cells;Biomolecules and Biomedicine;2024-09-06

2. PLGA nanocapsules as a delivery system for a recombinant LRP‐based therapeutic;FEBS Open Bio;2024-05-03

3. Phospholysine phosphohistidine inorganic pyrophosphate phosphatase suppresses insulin‐like growth factor 1 receptor expression to inhibit cell adhesion and proliferation in gastric cancer;MedComm;2024-01-30

4. Treatment strategies and drug resistance mechanisms in adenocarcinoma of different organs;Drug Resistance Updates;2023-11

5. Emerging roles of the cellular prion protein (PrPC) and 37/67 kDa laminin receptor (RPSA) interaction in cancer biology;Cellular and Molecular Life Sciences;2023-07-15